Georg Stingl

Active 1976–2024

124
Papers
21,046
Citations
90
h-index
123
i10-index

Citations

Citations per year for Georg Stingl1962: 1 citations1977: 2 citations1978: 12 citations1979: 28 citations1980: 74 citations1981: 53 citations1982: 52 citations1983: 48 citations1984: 42 citations1985: 44 citations1986: 49 citations1987: 47 citations1988: 55 citations1989: 92 citations1990: 70 citations1991: 46 citations1992: 57 citations1993: 51 citations1994: 54 citations1995: 61 citations1996: 57 citations1997: 62 citations1998: 89 citations1999: 110 citations2000: 129 citations2001: 128 citations2002: 130 citations2003: 129 citations2004: 118 citations2005: 142 citations2006: 115 citations2007: 105 citations2008: 136 citations2009: 116 citations2010: 144 citations2011: 130 citations2012: 136 citations2013: 118 citations2014: 120 citations2015: 124 citations2016: 149 citations2017: 168 citations2018: 146 citations2019: 432 citations2020: 422 citations2021: 386 citations2022: 285 citations2023: 244 citations2024: 335 citations2025: 154 citations2026: 2 citations1963–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,051 citing papers, 24.4% of this breakdownGermany: 748 citing papers, 8.9% of this breakdownUnited Kingdom: 621 citing papers, 7.4% of this breakdownFrance: 394 citing papers, 4.7% of this breakdownChina: 355 citing papers, 4.2% of this breakdownJapan: 347 citing papers, 4.1% of this breakdownAustria: 338 citing papers, 4% of this breakdownItaly: 333 citing papers, 4% of this breakdownSwitzerland: 325 citing papers, 3.9% of this breakdownCanada: 260 citing papers, 3.1% of this breakdownNetherlands: 250 citing papers, 3% of this breakdownAustralia: 206 citing papers, 2.5% of this breakdown
0%24.4%Other 25.8%

Fields

  • Medicine50.5%
  • Immunology and Microbiology35.8%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • Environmental Science1.1%
  • Neuroscience0.8%
  • Other3%

Topics

  • Dermatology and Skin Diseases8.3%
  • Immunotherapy and Immune Responses6.9%
  • T-cell and B-cell Immunology6%
  • Psoriasis: Treatment and Pathogenesis5.1%
  • Allergic Rhinitis and Sensitization4.7%
  • Asthma and respiratory diseases4.3%
  • Other64.7%

Coauthors

All papers

Open in search
  1. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula - New England Journal of Medicine 2015 cited by 806

  2. Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine

    Authors: , , , , , , , , , , , , , , , , , - Journal of Innate Immunity 2016 cited by 406

  3. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder

    Authors: , , , , , , , , , , , , , , , , - Journal of Investigative Dermatology 2016 cited by 377

  4. Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis

    Authors: , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2021 cited by 108

  5. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian J. Nickoloff, Yves Dutronc, Lotus Mallbris, Jonathan Janes, Amy M. DeLozier, Fabio P. Nunes, Amy S. Paller - Journal of the American Academy of Dermatology 2020 cited by 178

  6. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma

    Authors: , , , , , , , , , , , - Molecular Cancer 2021 cited by 76

  7. Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaj Sørensen, Henrik Bjørn Nielsen, Rasmus Toft‐Kehler, Emma Guttman‐Yassky, Georg Stingl, Markus Zeitlinger, Morten Otto Alexander Sommer - Clinical and Translational Medicine 2022 cited by 48

  8. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2012 cited by 361

  9. Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 108

  10. GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alice Wiesner, Stefan Wöhrl, Torsten Zuberbier - Allergy 2009 cited by 374

  11. Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL‐17A inhibition in psoriasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Experimental Dermatology 2015 cited by 202

  12. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2012 cited by 682

  13. Specific roles for dendritic cell subsets during initiation and progression of psoriasis

    Authors: , , , , , , , , , , - EMBO Molecular Medicine 2014 cited by 119

  14. Delayed antiretroviral therapy in HIV-infected individuals leads to irreversible depletion of skin- and mucosa-resident memory T cells

    Authors: , , , , , , , , , , , , , , , , - Immunity 2021 cited by 42

  15. Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials

    Authors: , , , , , , , - Acta Dermato Venereologica 2022 cited by 28

  16. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

    Authors: , , , , , , , , , , - Blood 2013 cited by 124

  17. In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed Skin

    Authors: , , , , , , , , , - Journal of Investigative Dermatology 2016 cited by 90

  18. IgE Depletion with Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis

    Authors: , , , , , , , , - Journal of Investigative Dermatology 2023 cited by 18

  19. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells

    Authors: , , , , , - The Journal of Experimental Medicine 2007 cited by 352

  20. GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Wöhrl, Torsten Zuberbier - Allergy 2009 cited by 306

  21. A Comparative Proteomic Study of Human Skin Suction Blister Fluid from Healthy Individuals Using Immunodepletion and iTRAQ Labeling

    Authors: , , , , , , , , , - Journal of Proteome Research 2012 cited by 78

  22. Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis

    Authors: , , , , , , , , - PLoS ONE 2017 cited by 75

  23. Classification of anti-FcϵRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2002 cited by 256

  24. Identification and Characterization of pDC-Like Cells in Normal Mouse Skin and Melanomas Treated with Imiquimod

    Authors: , , , , , - The Journal of Immunology 2004 cited by 199